Impaired peroxisomal beta-oxidation in microglia triggers oxidative stress and impacts neurons and oligodendrocytes

Ali Tawbeh1, Catherine Gondcaille1, Fatima-Ezzahra Saih1

  • 1Centre des Sciences du Goût et de l'Alimentation, CNRS, INRAE, Institut Agro, University of Bourgogne, Dijon, France.

PubMed

Insights

Peroxisomal deficiencies in microglia amplify neuroinflammation and oxidative stress, harming neurons and oligodendrocytes. This dysfunction may drive early neurodegeneration in X-linked adrenoleukodystrophy (X-ALD).

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia, the central nervous system's immune cells, drive neuroinflammation in neurodegenerative diseases.
  • Abnormal microglial activation is a key factor in peroxisomal leukodystrophies like X-linked adrenoleukodystrophy (X-ALD).

Purpose of the Study:

  • To investigate how peroxisomal deficiencies affect microglial oxidative properties.
  • To determine the impact of these altered microglia on neurons and oligodendrocytes.

Main Methods:

  • Utilized BV-2 microglial cells deficient in peroxisomal proteins ABCD1, ABCD2, or ACOX1.
  • Analyzed gene expression, reactive oxygen species (ROS), and nitric oxide (NO) production.
  • Assessed neuronal and oligodendrocyte apoptosis, morphology, and function using conditioned media from mutant microglia.

Main Results:

  • Mutant microglia showed heightened inflammatory and redox responses after lipopolysaccharide (LPS) stimulation, with increased ROS and NO.
  • Conditioned media from stimulated mutant microglia induced apoptosis in neurons and oligodendrocytes.
  • Neurons exposed to conditioned media displayed reduced complexity and altered neuropeptide secretion.

Conclusions:

  • Peroxisomal impairments in microglia exacerbate inflammation and oxidative stress, compromising neuronal and oligodendrocyte health.
  • This microglial dysfunction contributes to neurodegeneration in X-ALD by sustaining neuroinflammatory cascades.
  • Targeting microglial activation pathways offers potential therapeutic strategies for X-ALD and similar disorders.